MAL and prostate carcinoma: Thus, based on our results, WFA‐ and MAL I ‐reactive PSA‐glycoforms are not optimal markers for prostate cancer detection, although direct comparison of tissue and serum glycoforms may be hampered, e.g., by the presence of glycosidases in blood circulation [44].